Audiological Benefit With Non-implantable Bone Conduction Hearing Systems
Primary Purpose
Hearing Loss, Conductive
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Non-invasive bone conduction hearing aid A
Non-invasive bone conduction hearing aid B
Sponsored by
About this trial
This is an interventional treatment trial for Hearing Loss, Conductive
Eligibility Criteria
Inclusion Criteria:
- Written informed consent
- Adults (age ≥ 18 years on the test date)
- Normal hearing thresholds (AC/BC-thresholds ≤ 20 dB HL, 0.25 to 8 kHz)
- German native speakers
- Willingness and ability to perform all tests required for the study
Exclusion Criteria:
- Lack of compliance with any inclusion criteria
- Allergy against silicon (ear mold casting mass)
Sites / Locations
- Hearing Research Laboratory, University Hospital Bern
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
AB arm
BA arm
Arm Description
Sequence: Aided with non-invasive bone conduction hearing aid A Aided with non-invasive bone conduction hearing aid B
Sequence: Aided with non-invasive bone conduction hearing aid B Aided with non-invasive bone conduction hearing aid A
Outcomes
Primary Outcome Measures
Speech reception threshold in noise (S0NDIFF)
Speech reception threshold in noise (in dB SNR) measured with speech presented from the front (0° azimuth) and approximated diffuse noise presented from 4 speakers.
Secondary Outcome Measures
Speech reception threshold in noise (S90NDIFF)
Speech reception threshold in noise (in dB SNR) measured with speech presented from the right side (90° azimuth) and approximated diffuse noise presented from 4 speakers.
Speech reception threshold in noise (S270NDIFF)
Speech reception threshold in noise (in dB SNR) measured with speech presented from the left side (270° azimuth) and approximated diffuse noise presented from 4 speakers.
Sound localization
Mean absolute localization error (in degrees)
Subjective evaluation of the sound quality
Assessment of the sound quality with questionnaire by Gabrielsson et al.
Full Information
NCT ID
NCT03129191
First Posted
April 19, 2017
Last Updated
November 6, 2017
Sponsor
Insel Gruppe AG, University Hospital Bern
1. Study Identification
Unique Protocol Identification Number
NCT03129191
Brief Title
Audiological Benefit With Non-implantable Bone Conduction Hearing Systems
Official Title
Audiological Benefit With Non-implantable Bone Conduction Hearing Systems
Study Type
Interventional
2. Study Status
Record Verification Date
November 2017
Overall Recruitment Status
Completed
Study Start Date
July 1, 2017 (Actual)
Primary Completion Date
November 6, 2017 (Actual)
Study Completion Date
November 6, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Insel Gruppe AG, University Hospital Bern
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Recently, a new non-invasive bone conduction hearing aid was introduced. The system is connected directly to the skin with an adhesive adapter to transmit the sound to the inner ear through bone vibrations. The objective of this study is to evaluate and compare the audiological benefit of the new bone conduction hearing aid and compare it to an existing bone conduction hearing aid in normal hearing adults with bilateral simulated conductive hearing loss.
An evaluation of the improvement on speech understanding in noise and sound localization allows to estimate the system performance and enables to derive recommendations for clinical usage of the novel hearing system. It is hypothesized that in the bilateral condition similar speech understanding in noise and sound localization performance can be achieved with the new system compared to existing bone conduction hearing aids that are pressed against the skull using a soft band.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hearing Loss, Conductive
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
AB arm
Arm Type
Active Comparator
Arm Description
Sequence:
Aided with non-invasive bone conduction hearing aid A
Aided with non-invasive bone conduction hearing aid B
Arm Title
BA arm
Arm Type
Active Comparator
Arm Description
Sequence:
Aided with non-invasive bone conduction hearing aid B
Aided with non-invasive bone conduction hearing aid A
Intervention Type
Device
Intervention Name(s)
Non-invasive bone conduction hearing aid A
Intervention Description
The intervention is a non-invasive bone conduction hearing device which is retained on the patient's head with an elastic headband.
Intervention Type
Device
Intervention Name(s)
Non-invasive bone conduction hearing aid B
Intervention Description
The intervention is a non-invasive bone conduction hearing device which is retained on the patient's head with an adhesive adapter that is placed behind the auricle.
Primary Outcome Measure Information:
Title
Speech reception threshold in noise (S0NDIFF)
Description
Speech reception threshold in noise (in dB SNR) measured with speech presented from the front (0° azimuth) and approximated diffuse noise presented from 4 speakers.
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
Speech reception threshold in noise (S90NDIFF)
Description
Speech reception threshold in noise (in dB SNR) measured with speech presented from the right side (90° azimuth) and approximated diffuse noise presented from 4 speakers.
Time Frame
Day 1
Title
Speech reception threshold in noise (S270NDIFF)
Description
Speech reception threshold in noise (in dB SNR) measured with speech presented from the left side (270° azimuth) and approximated diffuse noise presented from 4 speakers.
Time Frame
Day 1
Title
Sound localization
Description
Mean absolute localization error (in degrees)
Time Frame
Day 1
Title
Subjective evaluation of the sound quality
Description
Assessment of the sound quality with questionnaire by Gabrielsson et al.
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Written informed consent
Adults (age ≥ 18 years on the test date)
Normal hearing thresholds (AC/BC-thresholds ≤ 20 dB HL, 0.25 to 8 kHz)
German native speakers
Willingness and ability to perform all tests required for the study
Exclusion Criteria:
Lack of compliance with any inclusion criteria
Allergy against silicon (ear mold casting mass)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Kompis, Prof
Organizational Affiliation
University Hospital Bern, Inselsptial
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hearing Research Laboratory, University Hospital Bern
City
Bern
ZIP/Postal Code
3008
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Audiological Benefit With Non-implantable Bone Conduction Hearing Systems
We'll reach out to this number within 24 hrs